RxDoctor Payments Data

Randall Kenninger, MD

Family Medicine · Fargo, NDNPI 1013934785

Payments from drug & device makers

$917in general payments, 2019–2025

Across 61 payments — averaging $15.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$305
  • Novo Nordisk$260
  • Merck$165
  • AstraZeneca$80
  • Pfizer$45
  • Abbott$37
  • plus $25 from 2 others

What the payments were for

  • Food & beverage$917100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$917 in reported general payments places this provider in the 80th percentile of 337 family medicine providers in North Dakota.

See all family medicine providers in North Dakota

Medicare billing

Part B allowed, 2024
$81,321
Medicare patients
464
Services billed
1,329

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban167$144,853
OzempicSemaglutide108$142,154
XareltoRivaroxaban61$54,017
MounjaroTirzepatide51$53,979
JanuviaSitagliptin Phosphate54$50,078
TrulicityDulaglutide34$40,934
Tresiba Flextouch U-200Insulin Degludec28$40,239
RybelsusSemaglutide17$32,032
JardianceEmpagliflozin37$27,110
Breo ElliptaFluticasone/Vilanterol27$12,187
EntrestoSacubitril/Valsartan15$11,320
Rosuvastatin Calcium662$10,373
Tresiba Flextouch U-100Insulin Degludec12$9,746
Atorvastatin Calcium746$8,962
Spiriva HandihalerTiotropium Bromide16$8,727

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$260$174,186125 claims
PfizerEliquis$45$144,853167 claims
Johnson & JohnsonXarelto$11$54,01761 claims
MerckJanuvia$165$50,07854 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 337 family medicine providers in North Dakota.

Other family medicine in Fargo

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →